04, 2025 (GLOBE NEWSWIRE) -- Noom , the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced the launch of the Noom Microdose GLP-1 Rx Program, a groundbreaking offering designed to unlock weight loss and long-term health benefits while minimizing side effects through personalized microdoses of GLP-1 medication, when clinically appropriate
They can assess your individual health needs, discuss the risks and benefits of different medications, and help you determine the best course of action
For weekly injectables like Wegovy or Zepbound, you can take the dose within 5 days of your normal schedule
Marika Mikelsaar, ME-3 is a unique probiotic strain with distinctive antioxidative properties
It gives your body the amino acids it needs to grow thicker, stronger hair
Understanding your genetic peptide profile allows PlexusDx providers to tailor your semaglutide dose and treatment strategy with greater precision